TW570980B - Latent baculovirus expression system - Google Patents

Latent baculovirus expression system Download PDF

Info

Publication number
TW570980B
TW570980B TW89111871A TW89111871A TW570980B TW 570980 B TW570980 B TW 570980B TW 89111871 A TW89111871 A TW 89111871A TW 89111871 A TW89111871 A TW 89111871A TW 570980 B TW570980 B TW 570980B
Authority
TW
Taiwan
Prior art keywords
baculovirus
virus
scope
item
patent application
Prior art date
Application number
TW89111871A
Other languages
Chinese (zh)
Inventor
Yu-Chan Chao
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/361,474 external-priority patent/US6245528B1/en
Application filed by Academia Sinica filed Critical Academia Sinica
Application granted granted Critical
Publication of TW570980B publication Critical patent/TW570980B/en

Links

Abstract

The invention relates to a baculovirus including a disruption in its endogenous p35 gene and its use in establishing latent baculovirus infections. In some embodiments, the baculovirus can also include a sequence encoding a non-baculovirus RNA and a baculovirus early gene promoter which drives expression of the non-baculovirus RNA.

Description

^ lyjyoyj A7 B7 五、發明說明(1 iOLiLi青案的前彳 本案係基於1998年7月28日申請之 第60/094,411號主張優先權。 2 &時專利申請案 發明背景: 桿狀病毒科的病毒,通f稱為桿“毒,是鱗翅目 的致命性病原。此等病毒通常藉由在昆蟲組織之生/、、、六 裂性感染而殺死其宿主。 、 吟 桿狀病毒通常含有長度約 錐π mjA 1 rw 土 160kb <共價封閉的環狀 :基因、组。該基因組能夠容納相對上較長的異種性 序=此外,在生產性感染期間’可達到高含量的結構性 病母蛋白質合成。結果’桿狀病毒/昆蟲細胞系統已在學 術研究和工業應用上成為普遍的蛋白質表現媒介。然而, 外 因為桿狀病毒感染末期會溶裂細胞,因此基因工程蛋白 逸,難以濃縮及純化。 發明概诚_ : 以 潛 性 的 本發明係基於發現若破壞桿狀病毒的p35基因,則能夠 建立潛伏性感染(此感染過程中,病毒大部分或所有晚期 基因表現被阻斷’但容許早期基因表現)。結果,藉由 具有中斷< 基因及由桿狀病毒早期啟動子(即能夠在 伏感染中推動桿狀病毒表現的任何啟動子)推動的外源 基因的桿狀病毒感染任何適當的宿主細胞,可建立持久 桿狀病毒表現培養系統。 4 本紙張尺度適用中國國家標準(CNS)A4規格公爱)- 570980 五、發明說明( 結果,藉感染任何含中斷p35基因及衍生自桿狀病毒早 期啟動子之桿狀病毒之適合寄主細胞,可建立持久性桿狀 病毒表現培養系統。 /、毛見7有p35-中斷之病毒的細胞,對桿狀病毒重覆感 木有抵抗力,亦即抵抗病毒再度感染。因此,可使用p35一 中斷的杯狀病毒來保護昆蟲,特別是在經濟上有價值的昆 蟲(例如蠶),免於病原性的桿狀病毒侵害。 因此,本發明的特徵為製造RNA及外源蛋白。p35基因 中斷的#狀病毒。孩桿狀病毒可進—步含有編碼第一個 RN^例如非·桿狀病毒RNA),以及推動第-個RNA表現 :才干狀病母早期基因啟動子(例如立即早期&因啟動子)之 # 、、序列第一個RNA可為編碼第一個蛋白質(例如非 才干狀病母蛋白質)的mRNA,如可檢測之蛋白質(例如 乳糖菩酶)。 該桿狀病毒亦可視需要含有第二個非桿狀病毒之RNA。 ^個非桿狀病毒之職可為第二個蛋白質(例如非桿狀 白質)的錢,例如可藉著螢光的、發光的或色原 二爾速檢測到其表現的蛋白質。也可以蛋白質表現 ==擇表現型的蛋白質。可選擇之表現型的實例 矣’抗有絲分裂樂物,如對新黴素或G418具抗性 病毒组成殷二 可用來推動得自桿狀 成啟動子之第二個蛋白質的表現,像是在第二個蛋 -5- 本紙張尺度適規格— (請先閱讀背面之注咅?事項再填寫本頁) ,丨-裝----_!丨訂-------. 經濟部智慧財產局員工消費合作社印製 297公釐) 570980 A7^ lyjyoyj A7 B7 V. Description of the invention (1) The former case of the iOLiLi case is based on priority claim No. 60 / 094,411 filed on July 28, 1998. Background of the 2 & patent application: Baculoviridae Viruses, commonly known as baculoviruses, are deadly pathogens of the order Lepidoptera. These viruses usually kill their hosts by infecting insect tissues. Hexaviruses usually contain The length is about π mjA 1 rw, 160 kb < covalently closed loop: gene, group. The genome can accommodate relatively long heterogeneous sequences = In addition, high levels of structural diseases can be reached during productive infections Parental protein synthesis. Results' The baculovirus / insect cell system has become a universal protein expression medium in academic research and industrial applications. However, because baculoviruses will lyse cells at the end of infection, genetically engineered proteins escape and are difficult to concentrate Sincerely, the invention is based on the discovery that latent infection can be established if the p35 gene of baculovirus is disrupted (during the infection, the virus Partial or all late gene expression is blocked 'but early gene expression is allowed). As a result, by having an interrupted < gene and by the baculovirus early promoter (i.e. any promoter that can promote baculovirus expression in av infection) ) A baculovirus promoted by an exogenous gene can infect any appropriate host cell to establish a persistent baculovirus expression culture system. 4 This paper is applicable to China National Standard (CNS) A4 specifications.)-570980 V. Description of the invention ( As a result, a permanent baculovirus expression culture system can be established by infecting any suitable host cell containing the interrupted p35 gene and a baculovirus derived from an early promoter of baculovirus. Cells, which are resistant to baculovirus repetitive susceptibility, that is, re-infection of the virus. Therefore, p35 interrupted caliciviruses can be used to protect insects, especially economically valuable insects (such as silkworms), Free from pathogenic baculovirus. Therefore, the present invention is characterized by the production of RNA and foreign proteins. # 35 virus with interrupted p35 gene. Child bacilli Virus can be further-contains encoding the first RN ^ (such as non-baculovirus RNA), and promote the expression of the first RNA: the genes of early genes promoters (such as immediate early & due to promoters) #, The first RNA of the sequence can be the mRNA encoding the first protein (such as the protein of the non-capillary disease patient), such as a detectable protein (such as lactosidase). The baculovirus can also contain a second non- rod if necessary. RNA of a baculovirus. A non-baculovirus can be the money for a second protein (such as non-baculo white matter), for example, its performance can be detected by fluorescent, luminescent, or chromogen. Protein. Protein expression can also be expressed as a phenotype. Examples of selectable phenotypes: 'Mitotic resistance, such as resistance to neomycin or G418 The virus can be used to drive the expression of a second protein from a rod-shaped promoter, Two eggs-5- This paper is of suitable size — (Please read the note on the back? Matters and then fill out this page), 丨 -install ----_! 丨 order -------. Ministry of Economic Affairs wisdom Printed by the Property Bureau's Consumer Cooperative (297 mm) 570980 A7

經濟部智慧財產局員工消費合作社印製 白質賦與藥物抗藥性時。 桿狀病毒早期啟動子(例如衍生自桿狀病毒^^丨基因的 啟動子),可在病毒生活史的早期推動表現的啟動子,也 就是正好在病毒進入後和表現大部份病毒之結構蛋白質之 前表現之啟動子。桿狀病毒組成啟動予(例如衍生自散休 克蛋白質基因之啟動子),為在桿狀病毒基因电 的前後關係中,可在病毒生活史的所有階段中推動其表現 的啟動子。桿狀病毒早期啟動予或桿狀病毒組成啟動子並 非必需衍生自桿狀病毒的基因組。衍生自其他生物和病毒 基因組的啟動子皆可用於本發明之桿狀病毒。 本發明亦包括藉著將本發明之桿狀病毒導人細胞中,來 表現非桿狀病毒RNA和非桿狀病毒蛋白質的方法。 本發明特徵亦在於藉著導入其内源的州基因中本有中 斷的第-個桿狀病毒細胞,並暴露該細胞至第二個桿狀病 毒而在細胞中抑狀病毒重覆感染的方法 細胞至第二個桿狀病毒接觸,,意指將該細胞或含有;= 的生物(例如裳)放在懷疑或已知含有桿狀病毒的環境中。 該環境可以是人造的(例如已經加人桿狀病毒的培養 或是在野外(例如已知有病原性桿狀病毒存在的Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs when white matter imparts drug resistance. Early baculovirus promoters (such as promoters derived from the baculovirus ^^ 丨 gene) are promoters that can promote performance early in the life history of the virus, that is, just after the virus enters and expresses the structure of most viruses A promoter previously expressed by a protein. Baculoviruses are composed of promoters (such as promoters derived from the gene for the protein of casual shock), and are promoters that promote their performance in all stages of the life cycle of the virus in the context of the baculovirus gene's electrical context. The baculovirus is activated early or the baculovirus promoter is not necessarily derived from the baculovirus genome. Promoters derived from the genomes of other organisms and viruses can be used in the baculovirus of the present invention. The present invention also includes a method for expressing non-baculovirus RNA and non-baculovirus protein by introducing the baculovirus of the present invention into human cells. The present invention is also characterized by a method for reinfecting a virus in a cell by introducing an interrupted first baculovirus cell in its endogenous state gene and exposing the cell to a second baculovirus. Cells come in contact with a second baculovirus, which means that the cell or an organism (such as a skirt) containing; = is placed in an environment suspected or known to contain baculovirus. The environment can be man-made (such as cultures with human baculovirus added) or in the wild (such as those known to have pathogenic baculovirus)

在本文中所使用,"抑制” 一詞咅 P 者。 Μ扣几王抑制和部份抑制兩 基因的中斷為在基因中的任何刪除(例如刪除啟動基因 ί·---麵!裝--------訂-------.0, (請先閱讀背面之注意事項再填寫本頁)As used herein, the term " inhibition " 咅 P. The interruption of two genes, M. quinquelus, and partial inhibition, is any deletion in the gene (for example, deletion of the starter gene.. ------- Order -------. 0, (Please read the notes on the back before filling this page)

本紙張尺度適用中關家Α4規格⑵〇 χ 29~ 570980 A7 B7 4 五、發明說明( :列)、插入或其他突變,丨由於轉錄作用的喪失或錯誤 ㈢不軲澤作用的喪失或錯誤指示’或蛋白質功能所 胺基酸序列的喪失,而使基因成為無功能的。 而 本發明之桿狀病毒和方法,提供了可用於學術和工業兩 者之中的新穎真核蛋白質表現系、统。不像先前的桿狀病毒 表現系其特徵在於溶解性感染。本發明之桿狀病毒和 万法使得利用#久性才旱狀病毒感染之培養物而製備的表現 可能的。此外,本文中描述的桿狀病毒 上對桿狀病母重覆感染具抗性的細胞,為保護在經濟上有 4貝值之比蟲免於桿狀病毒謗發之疾病侵害的第一步。 本發明其它特徵或優點,可自下列的圖片和詳細說明, 以及從申請專利範圍而明顯瞭解。 垦^簡要說明: 固為/、中已經使户35基因中斷,並導入iacz和neo基因之 桿狀病毒基因組區域的圖解說明。 本發明係關於具有中斷的户35基因的桿狀病毒。此等桿 狀病毒在昆蟲細胞中建立潛伏的病毒感染,導致兩個重要 的結果。第一,桿狀病毒的潛伏狀態,可用來在持久的培 養物中表現蛋白質。其次,桿狀病毒的潛伏狀態阻斷後續 杯狀病毒之感染。後者的觀察結果提供了保護在經濟上有 饧值之比蟲免於桿狀病毒謗發之疾病侵害的方法。 -----^--------t---- (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製The specifications of this paper are applicable to Zhongguanjia A4 specifications 〇χ 29 ~ 570980 A7 B7 4 V. Description of the invention (: column), insertion or other mutations, 丨 due to loss or error of transcription effect ㈢ loss or error indication of failure effect 'Or the loss of amino acid sequence of the protein function, making the gene non-functional. And the baculovirus and method of the present invention provide a novel eukaryotic protein expression system and system that can be used in both academic and industrial fields. Unlike previous baculovirus manifestations, it is characterized by a lytic infection. The baculovirus and the method of the present invention make it possible to perform the performance of the cultures prepared with #perennial dry virus infection. In addition, the baculovirus described in this article is repeatedly infected with cells that are resistant to baculovirus mothers. This is the first step in protecting an economically stable mollusk from baculovirus-infected disease. . Other features or advantages of the present invention can be clearly understood from the following pictures and detailed description, and from the scope of patent application. Ken ^ Brief description: Guwei / China has interrupted the 35 gene of the household and introduced the iacz and neo genes into the baculovirus genome region. The present invention relates to a baculovirus with a disrupted household 35 gene. These baculoviruses establish a latent viral infection in insect cells, leading to two important results. First, the latent state of baculoviruses can be used to express proteins in persistent cultures. Second, the latent state of baculovirus blocks subsequent calicivirus infections. The latter observations provide a way to protect economically valuable maggots from diseases that are flared by baculovirus. ----- ^ -------- t ---- (Please read the notes on the back before filling out this page) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

570980 A7 _ B7 五、發明說明() 於p35 ATG起始密碼子之核甞酸+219至+849 )的同源區插入 質體pThsN90Z内,使兩個基因均位在p94和p35基因序列的 侧面,以產生轉移載體pTA35hsN90Z。藉由PCR產生此等 户料·和户35_專一的片段,並藉著DNA定序確認其序列。 藉由將AcMNPV基因組DNA和質體pTA35hsN90Z共轉染到 TN368細胞中以進行同源重組作用。重組病毒稱為vAcZa p35,係藉以X-gal染色後藉帶有包涵體的藍色斑點篩選轉 染的TN368細胞而選殖,並在經過感染的sf21細胞中,藉 著缺乏包涵體的形成進一步地加以證實。在所有的篩選中 使用抗生素G418 ( 2亳克/毫升),除去任何的野生型病毒。 藉著其基因組DNA的限制輿圖並藉由其在感染Sf21細胞時 謗導之細胞凋零,進一步證實重組病毒。 在本實例中使用的第二個AcMNPV為vAcAnh,又稱為減 火者,如同在 Clem 等人,Science 254:1388-1390, 1991 中的描 述。該病毒在户35基因中含有754個鹼基對的刪除,導致截 短的p35蛋白質,從其羧基終端漏失132個胺基酸。 對於互補研究,創造出;735表現質體pKi35hN。該質體含 有由AcMNPV之iel基因啟動子推動之;735基因之完整開放讀 框。將長度為677個驗基對的hr5促進子序列(Guarino等人, J Virol 60:215-223,1986)導入仏/啟動子的上游。該neo基因則 由上述的果蠅啟動子推動。欲產生表現;?35的細胞 株,使用 CellFECYINTM(Life Technologies)將 pKi35hN 轉染至昆 -9- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注咅?事項再填寫本頁) ----訂--------· 經濟部智慧財產局員工消費合作社印製 經濟部智慧財產局員工消費合作社印製 570980 A7 B7 五、發明說明(7 ) 蟲的細胞内。在2毫克/毫升G418的存在下培養新徽素-抗 性的純種系兩週,並分離三個個別的純種系。對於感染的 實驗,將秋黏蟲(& (草地夜蛾(fallarmyworm))細胞 株Sf9和Sf21AE,以及粉紋夜蛾⑽/a m·)(甘藍銀紋夜 蛾(cabbagelooper))細胞株TN368,維持在26°C,補充有8%胎 牛血清的TNM-FH培養基(Life Technologies)中。在TN368細胞 中繁殖每一病毒。藉著使用TN368細胞之菌斑分析而估計 病毒的力價。 當Sf21細胞被vAcAnh病毒或vAcZAp35病毒感染時,大部 份的細胞經由細胞凋零而溶解。在感染後7天存活的細胞 導致持續感染的細胞純種系。被野生型病毒或解救 的突變種 vAsB6-l (BirnBaum 等人,J Virol 68:2521-2528, 1994)感染,則不產生持久的純種系。因此,持久病毒感染 的壓抑並不是因為專一的p35功能,反而較有可能由於直 接或間接與細胞凋零之阻斷有關的一般影響。 為確認阻斷持久的病毒感染,以感染力價(m〇i) 5 〇之 vAcAnh感染pKih35hN後穩定地轉染4xl04個Sf21細胞。在感 染後七天,清楚地看到病毒的包涵體,暗示足以互補在 vAcAnh中之缺陷的含量之有功能的p35產生於此等細胞 中。此等培養物不曾產生持久的純種系,表示持久的病毒 感染相關p35功能的缺乏,而非在病毒基因組中,户%基因 位置的任何順式(cb)影響。評估各種;735突變種建立持久 -10- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) -—裝 訂------- 570980 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明( 感染之細胞純種系的能力。以每孔4xi〇4個細胞的密度,將 親代細胞(Sf9或Sf21)接種在96·孔的培養盤並以各種m〇i的570980 A7 _ B7 V. Description of the invention () The homologous region of the nucleotide (+219 to +849) of the p35 ATG start codon was inserted into plastid pThsN90Z, so that both genes were located in the p94 and p35 gene sequences. Flanking to generate the transfer vector pTA35hsN90Z. These household-specific and household-specific 35-specific fragments were generated by PCR, and their sequences were confirmed by DNA sequencing. AcTNPV genomic DNA and plastid pTA35hsN90Z were co-transfected into TN368 cells for homologous recombination. The recombinant virus, called vAcZa p35, was selected by X-gal staining and transfected TN368 cells were screened by blue spots with inclusion bodies. In infected sf21 cells, the lack of inclusion body was further used to further colonize To confirm. The antibiotic G418 (2 g / ml) was used in all screenings to remove any wild-type virus. Recombinant viruses were further confirmed by their restriction maps of genomic DNA and by the withering of cells that they had defied when infecting Sf21 cells. The second AcMNPV used in this example is vAcAnh, also known as the fire reducer, as described in Clem et al., Science 254: 1388-1390, 1991. The virus contains a deletion of 754 base pairs in the H.35 gene, causing the truncated p35 protein to lose 132 amino acids from its carboxyl terminal. For complementary research, 735 were created for pKi35hN. This plastid contains the iel gene promoter driven by AcMNPV; the 735 gene has a complete open reading frame. A hr5 promoter sequence (Guarino et al., J Virol 60: 215-223, 1986) of 677 base pairs was introduced upstream of the 仏 / promoter. The neo gene is driven by the Drosophila promoter described above. If you want to produce performance;? 35 cell line, use CellFECYINTM (Life Technologies) to transfect pKi35hN to Kun-9- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) (Please read the back Note 咅? Please fill in this page again.) ---- Order -------- · Printed by the Employees 'Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Printed by 570980 A7 B7 (7) Intracellular of the insect. Neosemisinin-resistant pure germlines were cultured in the presence of 2 mg / ml G418 for two weeks, and three individual pure germlines were isolated. For infection experiments, & (fallarmyworm) cell lines Sf9 and Sf21AE, and Spodoptera litura (am ·) (cabbage looper) cell line TN368, TNM-FH medium (Life Technologies) supplemented with 8% fetal bovine serum was maintained at 26 ° C. Each virus was propagated in TN368 cells. Viral force was estimated by plaque analysis using TN368 cells. When Sf21 cells are infected with vAcAnh virus or vAcZAp35 virus, most of the cells are lysed by cell dying. Cells that survived 7 days after infection resulted in a purely germline of persistently infected cells. Infection with a wild-type virus or a rescued mutant vAsB6-l (BirnBaum et al., J Virol 68: 2521-2528, 1994) does not produce persistent pure lines. Therefore, suppression of persistent viral infections is not due to specific p35 function, but rather more likely to be due to general effects directly or indirectly related to the blocking of cell death. In order to confirm the blocking of persistent viral infection, 4 × 104 Sf21 cells were stably transfected after infection with pKih35hN with vAcAnh of infectivity (m0i) 50. Seven days after infection, virus inclusions were clearly seen, suggesting that functional p35 was produced in these cells sufficient to complement the content of the defect in vAcAnh. These cultures have never produced persistent pure germlines, indicating a lack of p35 function associated with persistent viral infection, rather than any cis (cb) effect on% gene positions in the viral genome. Evaluate various; 735 mutants establish long-lasting-10- This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm) (Please read the precautions on the back before filling this page) ----- Binding ---- --- 570980 A7 B7 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. 5. A description of the invention (Ability of pure germline of infected cells. At a density of 4xi04 cells per well, the parental cells (Sf9 or Sf21) Inoculate in 96-well culture plates and

Hz-1、AcMNPV、vAcAnh、vAcZAp35 或 VAsB6_l 感染。在感染 後7至10天,藉著錐藍排阻(trypan blue exdusi〇n)測定存活細 胞的數目。將含有五個細胞以上的細胞純種系登記為可存 活的純種系。繁殖此等細胞以形成可能的單層。雖然有一 些純種系在繁殖期間死亡,但藉著以某種濃度之某種病毒 感染所形成之原始菌落的數目,依然可有效地測量個別病 母之囷洛形成潛力。 只有vAcAnh和vAcZAp35能夠產生持久感染的純種系。以 野生型或VAsB6-l病毒,以廣範圍力價感染的細胞中,並 未觀察到此等純種系。在此等實驗中,m〇i越高,產生的 菌落越多,暗示專一的病毒基因產物(們)促進了持久感染 之純種系的形成。該結果與p35阻斷進入病毒之持久性的 結論一致。Hz-1, AcMNPV, vAcAnh, vAcZAp35, or VAsB6_l infection. Seven to 10 days after infection, the number of viable cells was determined by trypan blue exdusion. A pure cell line containing more than five cells is registered as a viable pure line. These cells are propagated to form a possible monolayer. Although some pure germlines die during reproduction, the number of primary colonies formed by infection with a certain concentration of a virus can still effectively measure the formation potential of individual mothers. Only vAcAnh and vAcZAp35 were able to produce purely germline with persistent infection. No such pure germline was observed in cells infected with wild type or VAsB6-l virus at a wide range of potency. In these experiments, the higher the m0i, the more colonies were generated, suggesting that the specific viral gene product (s) promoted the formation of pure germline of persistent infection. This result is consistent with the conclusion that p35 blocks entry into the virus.

Π ·捷_久感染之純種系保存了病喜的DNA 欲建立以桿狀病毒持久感染的專一純種系之培養物,在 24-孔的培養盤中,利用vAcAnh和vAcZAp35,以50$m〇i接 種母孔2xl05個細胞。接種後兩週,存活的細胞純種系成為 可見的。分離純種系,轉移至96-孔的培養盤内,並使其 生長7 -10天,每3-4天更換一次培養基。 將存活的純種系分別移至24-孔的培養盤中,如仍在生 -11 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)" ---------- (請先閱讀背面之注意事項再填寫本頁) 一—裝---- 訂_Π · Jie_The long-infected pure germline has preserved the disease-loving DNA. To establish a unique pure germline culture that is persistently infected with baculovirus, in a 24-well culture plate, use vAcAnh and vAcZAp35 for 50 $. Moi was seeded into 2 x 105 cells in the mother well. Two weeks after the inoculation, a pure line of viable cells became visible. The pure germline was isolated, transferred to a 96-well culture plate, and allowed to grow for 7-10 days, and the medium was changed every 3-4 days. Move the surviving pure germline to a 24-well culture plate, if still alive -11-This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) " ----- ----- (Please read the notes on the back before filling this page)

經濟部智慧財產局員工消費合作社印製 570980 五、發明說明(9 ) 長’則移至較大的培養盤或燒瓶中。這些運移物,平均每 10個原始的純種系中有大約3 _ 6個純種系存活。在傳代 時’顯然因為細胞凋零而喪失純種系。此等純種系係生長 於由50%新鮮培養基和50%調整培養基所組成的培養基。 建立兩、组持久感染的細胞株,並在後續的實驗中使用。 衍生自以vAcAnh的感染之四個持久感染的細胞株,稱為Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 570980 V. Description of Invention (9) The length is moved to a larger culture dish or flask. These transporters, on average, have about 3-6 pure germlines per 10 original pure lines. At the time of passage, 'the apparent loss of the pure germline was due to the withering of the cells. These pure germlines are grown on a medium consisting of 50% fresh medium and 50% adjusted medium. Two groups of persistently infected cell lines were established and used in subsequent experiments. Derived from four persistently infected cell lines infected with vAcAnh, called

Sf9_vAc-l、Sf9-vAc-2、Sf9-vAc-3 和 Sm-vAc-l。衍生自以 vAcZ △p35的感染之三個持久感染的細胞株,稱為Sf9_vAcZAp35_ 1、Sf9-vAcZAp35-2 和 Sf9-vAcZZXp35-3 欲在持久感染之細胞 中檢測極低含量的病毒DNA,藉由PCR自經過培養的細胞 中直接放大DNA。以磷酸緩衝之生理鹽水(PBS)沖洗細胞 兩次’並稀釋成1〇6個細胞/毫升。藉著加入9〇微升清潔劑 緩衝溶液(50mM KQ,l〇mM Tris-HCl(pH8.3),0.1 毫克 / 毫升明 膠,0.45%NP-40,0.45%吐溫-20,0·6毫克/亳升蛋白酶κ ), 使10微升該經過稀釋之懸浮液溶解。接著在60t:下培養該 經過稀釋之懸浮液1小時。培養後,在95 °C下15分鐘使蛋 白酶K失活。 藉由PCR放大10微升之該溶裂物,並藉著瓊脂糖凝膠電 泳分析。使用連續10-倍稀釋之質體pThsN90Z做為分子標準 物。同時以細胞溶裂物放大質體DNA以測定在以VAcAnh持 久感染之細胞中病毒DNA的量。兩個陰性對照組,包括無 模板DNA之反應混合物,以及僅含有Sf9細胞溶胞裂的反 -12 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 厂-裝 ---訂· 570980 A7 B7 10 五、發明說明() 應,係用於確定試劑中無污染的模板。 引子係互補於〆^基因之801-個鹼基對片段的5’和3’區。 在1.5%瓊脂糖凝膠上分級分離PCR產物,並藉著真空吸墨 器(Vacu GeneXL;Pharmacia LKB Biotechnology)移轉至尼龍膜 上。藉著隨機引子作用,以[a-32P]dCTP標示的p94基因片段 來探測該膜(Berhringer-Mannheim)。 為測定病毒DNA在細胞培養物中的存在,從未經感染和 持久感染的細胞中純化出總基因組DNA,並使用Hydri-Dot Manifold(Bio-Rad Laboratories)在尼龍膜上沾染墨點。藉著隨 機引子作用,以[a-32P]dCTP標示的病毒DNA來探測該膜。 藉著放射自顯術使墨點呈像,並進一步使用磷光顯影器 (Phosphor Imager)(Molecular Dynamics)定量 ° 最後,如下檢測病毒的轉錄本。利用Ultraspec RNA分離 試劑(Biotecx),自不同的細胞純種系製備總細胞RNA。為 檢測各種速發早期基因的表現,使用寡d(T)引子和莫洛尼 氏(moloney)老鼠白血病病毒(MMLV)-反轉錄酶,將10微克 總RNA反轉錄。藉由PCR,利用病毒ieO、iel和ie2基因的專 一引子和細胞gapdh基因放大等量的cDNA。 用於 PCR 之引子如下:ieO,GGCAACGCAACATGATAAGAC (序歹U 1线另J 1號)和GTTCAAGGGTTGCACAGCTT (序歹U識另U 2 號),其與相對於ieO之ATG起始密碼子之-11至+720的序列 互才甫;及iel ,ATCGTGAACAACCAAGTGA (序歹J識另4 3號)和 -13- ^^尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) !裝 訂--------- 經濟部智慧財產局員工消費合作社印製 經濟部智慧財產局員工消費合作社印製 570980 A7 B7 11 五、發明說明() GTTCAAGGGTTGCACAGCTT (序歹J識別4號),其與相對於 iel之ATG起始密碼子之-22至+520的序列互補(Chisolm等 人 , J Virol 62:3193-3200, 1988) ; ie2 , AACAGTATCCTACCAGCCCA (序 歹J 1 线 Μ 5 號)和 CCTCTACTTCTTCTTCGGGT (序歹J 1线另U 6號),其與才目對於ie2 之ATG起始密碼子之-23至+612的序列互補(Carson等人, Virology 182:279-286,1991) ; 以 及 GAPDH , GACGGACCCTCTGGAAAA (序 歹J 識 別 7 號)和 ACCAGCTGATGAGCTTGAC (序列識別8號),其相當於黃猩 獲果虫€ ⑽g(xs^er)gapdh基因的胺基酸殘基195至 310 (Lu 等人,J_ Virol 69:975-982, 1995)。 每個PCR進行30次循環。亦測試不具MMLV-反轉錄酶的 樣品以確保該片段係放大自mRNA。藉著電泳在1.2%瓊脂 糖凝膠上分離RT-PCR產物,並使用真空吸墨器(Vacu GeneXL; Pharmacia LKB Biotechnology)移至 MAGNA 尼龍轉移膜 (MSI)上。使該膜分別與以P-標示之對抗ieO、iel、ie2和 gapdh基因的探針,在60 °C下,在含有0.25M Na2HP04(pH7.2)、ImM EDTA、7%SDS、1%BSA 溶離份 V 和 10% 甲醯胺的雜交緩衝溶液中雜交過夜。 在所有被vAcAnh感染之持久感染的細胞中,病毒DNA係 藉著PCR檢測的,接著在80次傳代之後進行南方雜交作 用。在延長的連續傳代之後,當與vAcAnh-感染的細胞做 -14- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ------------裝--------訂--------1 (請先閱讀背面之注意事項再填寫本頁) 570980 經濟部智慧財產局員工消費合作社印制衣 A7 B7 12 五、發明說明() 比較時,藉著南方分析,在 Sf9-vAcZZ\p35-l、Sf9-vAcZZ\p35-2和Sf9_vAcZAp35-3細胞株中檢測到較高含量的病毒DNA内 容量。點上墨點的雜交作用證實了該共同趨勢。 此外,使用RT-PCR監視病毒早期基因的表現。此等早期 基因的表現可檢測於最初被野生型AcMNPV感染的Sf9細 胞。早期基因表現,在新近以滅火者(annibilator)vAcAnh感 染的細胞中,在建立潛伏之前亦是明顯的。而在被vAcAnh 持久感染的細胞中並未檢測到早期基因表現。相反的,大 多數的病毒早期基因係表現於藉著vAcZAp35建立之持久 細胞株Sf9-vAcZAp35-l和Sf9-vAcZAp35-2。所有得自此兩個 細胞株之受試早期基因的表現,均是相對上較強的,且與 被野生型病毒以產生性方式感染之細胞的早期基因表現無 法區別,這暗示在被感染的細胞中,病毒的基因組被維持 在失活的狀態。頃相信外源p35的表現可能釋放產生性感 染的障礙;如同下述來測試這個假設。在Sf9-vAcZZ\p35-3 細胞中並未檢測到早期基因的表現。 m.在桿狀病毒潛伏中表現非-桿狀病喜的蛋白皙Sf9_vAc-1, Sf9-vAc-2, Sf9-vAc-3, and Sm-vAc-1. Derived from three persistently infected cell lines infected with vAcZ △ p35, called Sf9_vAcZAp35_1, Sf9-vAcZAp35-2, and Sf9-vAcZZXp35-3. To detect very low levels of viral DNA in permanently infected cells, by PCR directly amplifies DNA from cultured cells. The cells were washed twice with phosphate-buffered saline (PBS) and diluted to 106 cells / ml. By adding 90 microliters of a detergent buffer solution (50mM KQ, 10mM Tris-HCl (pH8.3), 0.1 mg / ml gelatin, 0.45% NP-40, 0.45% Tween-20, 0.6 mg / Liter proteinase κ), solubilize 10 microliters of the diluted suspension. The diluted suspension was then incubated at 60t for 1 hour. After incubation, protease K was inactivated at 95 ° C for 15 minutes. Ten microliters of this lysate was amplified by PCR and analyzed by agarose gel electrophoresis. A serial 10-fold dilution of plastid pThsN90Z was used as the molecular standard. At the same time, plastid DNA was amplified with a lysate to determine the amount of viral DNA in cells that were permanently infected with VAcAnh. Two negative control groups, including the reaction mixture without template DNA, and anti-12 containing only lysing of Sf9 cells-this paper size applies to China National Standard (CNS) A4 (210 X 297 mm) (Please read first Note on the back, please fill out this page again) Factory-installation --- Order · 570980 A7 B7 10 V. Description of the invention () The application should be used to determine the template without contamination in the reagent. The primers are complementary to the 5 'and 3' regions of the 801-base pair fragment of the 〆 ^ gene. The PCR products were fractionated on a 1.5% agarose gel and transferred to a nylon membrane by means of a vacuum blotter (Vacu GeneXL; Pharmacia LKB Biotechnology). The membrane was probed with a p94 gene fragment marked by [a-32P] dCTP by random primers (Berhringer-Mannheim). To determine the presence of viral DNA in cell culture, total genomic DNA was purified from uninfected and persistently infected cells and stained with nylon dots on a nylon membrane using Hydri-Dot Manifold (Bio-Rad Laboratories). The membrane was detected by random DNA primers with viral DNA labeled with [a-32P] dCTP. Ink dots were imaged by autoradiography and further quantified using a Phosphor Imager (Molecular Dynamics). Finally, virus transcripts were detected as follows. Ultraspec RNA Isolation Reagent (Biotecx) was used to prepare total cellular RNA from different cell pure lines. To test the expression of various early-onset genes, 10 micrograms of total RNA was reverse transcribed using oligod (T) primers and moleoney mouse leukemia virus (MMLV) -reverse transcriptase. By PCR, the same primers of the virus ieO, iel, and ie2 genes and the cell gapp gene were used to amplify the same amount of cDNA. The primers used for PCR are as follows: ieO, GGCAACGCAACATGATAAGAC (sequence U 1 line and J 1) and GTTCAAGGGTTGCACAGCTT (sequence U 2 and U 2), which correspond to -11 to + of the ATG start codon relative to ieO The sequence of 720 is talented; and iel, ATCGTGAACAACCAAGTGA (in order to identify the other 4 3) and -13- ^ ^ standards are applicable to China National Standard (CNS) A4 specifications (210 X 297 mm) (Please read the back Note: Please fill out this page again!) Binding --------- Printed by the Employees 'Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs and printed by the Consumers' Cooperatives of the Ministry of Economics and Intellectual Property Bureau printed by 570980 A7 B7 11 V. Description of Invention () GTTCAAGGGTTGCACAGCTT ( Sequence number J identification number 4), which is complementary to the sequence of -22 to +520 of the ATG start codon relative to iel (Chisolm et al., J Virol 62: 3193-3200, 1988); ie2, AACAGTATCCTACCAGCCCA (Sequence number J 1 line M 5) and CCTCTACTTCTTCTTCGGGT (sequence J 1 line another U 6), which are complementary to the sequence of -23 to +612 of the ATG start codon for ie2 (Carson et al., Virology 182: 279-286, 1991); and GAPDH, GACGGACCCTCTGGAAAA (Preface J No. 7) and ACCAGCTGATGAGCTTGAC (sequence recognition number 8), which are equivalent to amino acid residues 195 to 310 of the chimpanzee fruitworm ⑽g (xs ^ er) gapdh gene (Lu et al., J_ Virol 69: 975- 982, 1995). 30 cycles were performed per PCR. Samples without MMLV-reverse transcriptase were also tested to ensure that the fragment was amplified from mRNA. RT-PCR products were separated on a 1.2% agarose gel by electrophoresis and transferred to a MAGNA nylon transfer membrane (MSI) using a vacuum blotter (Vacu GeneXL; Pharmacia LKB Biotechnology). The membrane was probed with P-labeled anti-ieO, iel, ie2, and gapdh genes, respectively, at 60 ° C at 0.25M Na2HP04 (pH7.2), ImM EDTA, 7% SDS, 1% BSA. Eluate V and hybridize in 10% formamidine in a hybridization buffer solution overnight. In all persistently infected cells infected with vAcAnh, viral DNA was detected by PCR, followed by southern hybridization after 80 passages. After extended serial passages, when done with vAcAnh-infected cells -14- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ------------ -------- Order -------- 1 (Please read the precautions on the back before filling this page) 570980 Printed clothing A7 B7 of the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Explanation () In the comparison, by Southern analysis, a higher content of viral DNA content was detected in Sf9-vAcZZ \ p35-1, Sf9-vAcZZ \ p35-2 and Sf9_vAcZAp35-3 cell lines. The hybridization of dots on dots confirms this common trend. In addition, RT-PCR was used to monitor the expression of early viral genes. The expression of these early genes can be detected in Sf9 cells originally infected with wild-type AcMNPV. Early gene expression was also apparent in newly infected cells with annibilator vAcAnh before establishing latency. No early gene expression was detected in cells permanently infected with vAcAnh. In contrast, most of the early viral gene lines of the virus appear in the durable cell lines Sf9-vAcZAp35-1 and Sf9-vAcZAp35-2 established by vAcZAp35. The performance of all the early genes tested in these two cell lines was relatively strong and indistinguishable from the early genes of cells infected with the wild-type virus in a productive manner, suggesting that the In the cell, the virus' genome is maintained in an inactive state. It is believed that the performance of exogenous p35 may release the barriers that produce sex; test this hypothesis as follows. No early gene expression was detected in Sf9-vAcZZ \ p35-3 cells. m. Protein expression of non-baculovirus in baculovirus latency

為測定是否β -半乳糖甞酶表現於以vAcZAp35感染之細胞 中表現,在室溫下,在含有2%甲醛、2%戊二醛、i5〇mM NaCl和15mM NaaHPO4的溶液中固定細胞5分鐘。接著以 150mM NaCl和15mM Na2HP04沖洗細胞兩次,並以含有1毫 克/毫升5 -溴-4-氯-3_ Θ卜朵基-β - D _ ρ比喃半乳糖:y:、5mM -15- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------Ί-----裝--------訂--------1 (請先閱讀背面之注意事項再填寫本頁) 570980To determine whether β-galactosidase was expressed in cells infected with vAcZAp35, the cells were fixed in a solution containing 2% formaldehyde, 2% glutaraldehyde, i50mM NaCl, and 15mM NaaHPO4 for 5 minutes at room temperature. . The cells were then washed twice with 150 mM NaCl and 15 mM Na2HP04, and contained 1 mg / ml 5-bromo-4-chloro-3_Θbutoryl-β-D_ρ galactan: y :, 5mM -15- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ------- Ί ----- installation -------- order -------- 1 (Please read the notes on the back before filling this page) 570980

發明說明( 經濟部智慧財產局員工消費合作社印製 在〇·1之moi處看到相對於Sf9和Sf2i,在死亡細胞的百分比 上有顯著的降低。 在以vAcZAp35持久感染的細胞中觀察到明顯的病毒抵抗 力。一般而言,在挑戰後三天,在任何上述的m〇i處,僅 有低於5%的細胞死亡。清楚的,帶有中斷之户“基因的桿 狀病毒可抑制溶解性桿狀病毒的重覆感染。 V · b_35可在持久感染的細胞中再活化病毒的產製 可在 Sf21-vAc-l、Sf9_vAc-l、Sf9_vAc-2 或 Sf9-vAc-3 中檢測到 無感染性的病毒。可在兩個持久的細胞株Sf9-VAcZZ\p35-lDescription of the invention (Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs at the moi of 0.1, there is a significant reduction in the percentage of dead cells relative to Sf9 and Sf2i. Obviously observed in cells persistently infected with vAcZAp35 In general, less than 5% of the cells died at any of the above three days after the challenge. It is clear that baculoviruses with a disrupted "gene" can inhibit Repeated infection with lytic baculovirus. V · b_35 can reactivate virus production in persistently infected cells and can be detected in Sf21-vAc-1, Sf9_vAc-1, Sf9_vAc-2 or Sf9-vAc-3 Non-infectious virus. Available in two persistent cell lines Sf9-VAcZZ \ p35-l

和Sf9-vAcZ\p35-2中檢測到低的病毒力價,但在Sf9-vAcZA p35-3細胞中則否。 為進一步研究是否可從這些持久感染的細胞中再活化有 感染性的病毒,我們將p35表現載體pKih35hN轉染至持久感 染的細胞株内。如上所述,以1微克質體pKih35hN轉染持 久感染的細胞株(2xl05個細胞/孔,在24-孔的培養盤中)。 以pKih35hN轉染親代的Sf9細胞做為對照組。在轉染後24小 時,以vAcZZ\p35在10之moi感染此等細胞。在轉染後6天 收獲培養基,並藉著菌斑測定使用TN368細胞定出釋放之 病毒的力價。 陽性對照組培養物產生豐富的傳染性病毒。得自以P35 表現質體轉染之Sf9-vAcZZ\p35-l和Sf9-vAcZAp35-2細胞之病 毒子代的產量增加,雖然並未戲劇化地增至對數的規模。 -17- I紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公t ) ' ----------裝--------訂--------1 (請先閲讀背面之注意事項再填寫本頁) 15570980 A7 經濟部智慧財產局員工消費合作社印製 五、發明說明(Low virions were detected in Sf9-vAcZ \ p35-2, but not in Sf9-vAcZA p35-3 cells. To further investigate whether infectious viruses could be reactivated from these persistently infected cells, we transfected the p35 expression vector pKih35hN into a persistently infected cell line. As described above, persistently infected cell lines (2 x 105 cells / well in a 24-well plate) were transfected with 1 microgram of pKih35hN. The parental Sf9 cells transfected with pKih35hN were used as a control group. 24 hours after transfection, these cells were infected with vAcZZ \ p35 at 10 moi. The culture medium was harvested 6 days after transfection and the viability of the released virus was determined by plaque assay using TN368 cells. Positive control cultures produced abundant infectious viruses. The yield of virus progeny from Sf9-vAcZZ \ p35-1 and Sf9-vAcZAp35-2 cells transfected with P35-expressing plastids increased, although it did not increase dramatically to a logarithmic scale. -17- I paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm t) '---------- installation -------- order ------- -1 (Please read the notes on the back before filling this page) 15570980 A7 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

另一方面,得自以P35表現質體轉染之Sf9_vAcZZVp35-3細胞 的病毒產量,戲劇化地增加至數個對數值。其他非-病毒· 產生的持久細胞株’在p35表現質體的轉染之後,sf9-vAcZ △p35-4 (在比前三個純種系更晚的日期建立)產生豐富的病 毒。 此等觀察指出,持久的桿狀病毒_感染細胞是真正的潛 伏’因為病毒之產製可由表現p35而謗發,藉此自潛伏至 產生性感染釋出障礙。 其他的具體實施例 將瞭解在描述本發明的同時,連同其詳細說明一起,先 前的說明企圖解釋而非限制本發明之範圍,其係由附加之 申請專利範圍的範圍來定義。其他的觀點、優點和修改, 亦在本發明的範圍内。 例如,雖然藉著桿狀病毒基因組序列的單一置換,達成 p35基因的中斷和一或多個非桿狀病毒基因的導入,但其 他的基因組修改亦在申請專利的範園内。編碼非桿狀病毒 RNA或本發明之序列的導人,可以在業已具有中斷之阳 基因之基因組内的任何位置。 18 Μ氏張尺度適用中_家標準(CNS)A4 g格⑵Q χ挪公爱)- --------·丨-裝--------訂---------·· (請先閱讀背面之注意事項再填寫本頁)On the other hand, virus production from Sf9_vAcZZVp35-3 cells transfected with p35 expressing plastids dramatically increased to several logarithmic values. Other non-virus · produced persistent cell lines' sf9-vAcZ Δp35-4 (established at a later date than the first three pure germline lines) produced a wealth of virus after transfection of p35-expressing plastids. These observations indicate that long-lasting baculovirus-infected cells are truly latent 'because the production of the virus can be slandered by the expression of p35, thereby releasing obstacles from latent to producing a sexual infection. Other specific embodiments will understand that while describing the present invention, together with its detailed description, the previous description is intended to explain rather than limit the scope of the invention, which is defined by the scope of the appended patent application. Other viewpoints, advantages, and modifications are also within the scope of the present invention. For example, although the interruption of the p35 gene and the introduction of one or more non-baculovirus genes are achieved by a single replacement of the baculovirus genome sequence, other genomic modifications are also within the scope of patent applications. A guide encoding non-baculovirus RNA or a sequence of the present invention can be anywhere in the genome that already has a disrupted positive gene. 18 MHZ scale is applicable to Chinese standard (CNS) A4 g grid Q 挪 Nogley love)--------- 丨 -installation -------- order ------ --- ·· (Please read the notes on the back before filling this page)

Claims (1)

第〇8911187〇號專利申請案 中文申請專利範圍替換年3再)——Patent No. 08911187〇 Chinese patent application scope replacement 3 years) 申請專利範圍 570980 1. :種桿狀病毒表現系統,其包含中斷之p35内源基因之 样狀病毒,其係用於建立連續性蛋白質表現系統。 2. 根據中請專利範圍第!項之捍狀病毒表現系統,其中样 狀病毒另包括第一個RNA序列。 3. «中請專利㈣第2項之捍狀病毒表現系統,其中該 第一個RNA為非桿狀病毒之RNA。 4. 根據申請專利範圍第3項之捍狀病毒表現系統,另包括 样狀病毒早期基因啟動子,其 祕的表現。 推動弟-個非样狀病毒 5. 請專利範圍第4項之捍狀病毒表現系統,其中該 中斷者為刪除之一部份。 ’、 其中該 6·根據申請專利範圍第5項之捍狀病毒表現系統 户35基因的一部份包括户%啟動子。 7·根據申請專利範圍第4項之捍狀病毒 甘 第-個非样狀病毒驗為編碼第—個蛋白^’其中該 8·根據申請專利範圍第7項之桿 貝又mRNA〇 第-個蛋白質是可檢測的。^表現系統,其中該 9.根據申請專利範圍第8項之捍狀病主 第-個蛋白質為β_丰乳糖#酶。其中該 10·根據申請專利範圍第7項之桿狀病主士 第-個蛋白質為非桿狀病毒的蛋白;表現系統,其中該 η.根據中請專利範圍第4項之桿狀病^表 兮衣現系統,另包揆 本纸張尺度適财S a家料(CNS)域格(21GX 29:^)Scope of application for patents 570980 1 .: A baculovirus expression system containing a p35 endogenous gene-like virus, which is used to establish a continuous protein expression system. 2. According to the patent scope of the request! The item-defense virus expression system, in which the sample virus additionally includes the first RNA sequence. 3. «Patented Patent» Item 2 of the defending virus expression system, wherein the first RNA is non-baculovirus RNA. 4. According to the defending virus expression system of item 3 of the patent application scope, including the early gene promoter of the like virus, its secret performance. Promote a non-virus-like virus 5. Please call for the protection of virus-like virus expression system in item 4 of the patent, in which the interruption is part of the deletion. ′, Among which 6. A part of the 35 gene of the defending virus expression system according to item 5 of the scope of patent application includes the household% promoter. 7. According to the scope of the patent application No. 4 of the protection of the virus Gan Gan-the first non-like virus is detected as encoding the first protein ^ 'where the 8. According to the scope of the patent application No. 7 of the rod-shaped mRNA Protein is detectable. ^ Performance system, where 9. The first protein according to claim 8 of the scope of patent application is the β_richlactose # enzyme. Among them, 10. The bacilli disease subject according to item 7 of the scope of the patent application, the first protein is a non-baculovirus protein; the expression system, wherein the η. According to the baculo disease of the fourth scope of the patent application ^ table Xi Yi system, in addition to the paper size suitable financial Sa Family (CNS) domain grid (21GX 29: ^) 攝碼第 病毒RNA的第二個序列。 該第/專利範圍第11項之桿狀病毒表現系統,其中 mRN;個非桿狀病毒隐為編碼第二個蛋白質的 13.根據申3杳鱼 甲叫專利範圍第12項之桿狀病毒表現系統 ^二個蛋白質為可選擇的。 14·根據中,杳査 +、μ _ π專利範圍第13項之桿狀病毒表現系統,其中 個蛋白質為新黴素抗性基因。 15.=申請專利範圍第12項之桿狀病毒表現系統,其中 该罘二個蛋白質為非桿狀病毒的蛋白質。 16·根據申請專利範圍第1〇項之样狀病毒表現系統,另包 連續性杯狀病毒啟動子,其推動第二個非样狀病毒 RNA的表現。 17·根據申請專利範圍第16項之桿狀病毒表現系統,其中 忒連續性捍狀病毒啟動子為仏户70啟動子。 18·根據申請專利範圍第4項之桿狀病毒表現系統,其中該 杯狀病毒早期基因啟動子因為样狀病毒户啟動子。 19. 一種在細胞中表現非桿狀病毒RNA之方法,該方法包 括將根據申請專利範圍第4項之桿狀病毒導入該細胞。 2〇· —種在細胞中表現非桿狀病毒蛋白質之方法,該方法 包括將根據申請專利範圍第7項之桿狀病毒導入該細 胞0 -2 - 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 8 8 8 8 A B c D 570980 々、申請專利範圍 21. —種在細胞中抑制桿狀病毒重覆感染之方法,該方法 包括將含有中斷之内源基因的第一個桿狀病毒導入 該細胞,並使該細胞暴露於第二個桿狀病毒。 22. 根據申請專利範圍第21項之方法,其中該中斷為刪除 基因之一部份。 23. 根據申請專利範圍第22項之方法,其中該户35基因的一 部份包括啟動子。 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)Code the second sequence of viral RNA. The baculovirus expression system of item 11 of the patent / scope of patents, in which mRN; a non-baculovirus is encoded as a second protein 13. According to the application of claim 3, the baculovirus expression of the baculovirus of the patent scope of project 3 is 12. System ^ Two proteins are optional. 14. According to the investigation, the baculovirus expression system according to item 13 of the patent scope of the + and μ_π patents, of which two proteins are neomycin resistance genes. 15. = The baculovirus expression system according to item 12 of the patent application, wherein the two proteins are non-baculovirus proteins. 16. According to the sample-like virus expression system of the scope of application patent No. 10, a continuous calicivirus promoter is also included, which promotes the expression of a second non-like virus RNA. 17. The baculovirus expression system according to item 16 of the scope of application for patents, wherein the 忒 continuous defender virus promoter is the 仏 70 promoter. 18. The baculovirus expression system according to item 4 of the scope of patent application, wherein the calicivirus early gene promoter is a virion-like promoter. 19. A method of expressing non-baculovirus RNA in a cell, the method comprising introducing a baculovirus according to item 4 of the scope of the patent application into the cell. 2〇 · —A method for expressing non-baculovirus protein in a cell, the method includes introducing a baculovirus according to item 7 of the patent application into the cell 0 -2-Chinese paper standard (CNS) Α4 is applied to this paper Specifications (210 X 297 mm) 8 8 8 8 AB c D 570980 々, patent application scope 21.-A method for inhibiting repeated infection of baculovirus in cells, the method includes A baculovirus is introduced into the cell and the cell is exposed to a second baculovirus. 22. The method according to item 21 of the patent application, wherein the interruption is part of deletion of a gene. 23. The method according to item 22 of the patent application, wherein a part of the 35 gene of the household includes a promoter. This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)
TW89111871A 1999-07-27 2000-06-16 Latent baculovirus expression system TW570980B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/361,474 US6245528B1 (en) 1998-07-28 1999-07-27 Latent baculovirus expression system

Publications (1)

Publication Number Publication Date
TW570980B true TW570980B (en) 2004-01-11

Family

ID=32594976

Family Applications (1)

Application Number Title Priority Date Filing Date
TW89111871A TW570980B (en) 1999-07-27 2000-06-16 Latent baculovirus expression system

Country Status (1)

Country Link
TW (1) TW570980B (en)

Similar Documents

Publication Publication Date Title
US6245528B1 (en) Latent baculovirus expression system
Hutoran et al. Description of an as yet unclassified DNA virus from diseased Cyprinus carpio species
Fleming Polydnaviruses: mutualists and pathogens
Strand Microplitis demolitor polydnavirus infects and expresses in specific morphotypes of Pseudoplusia includens haemocytes
Burke et al. Mutualistic polydnaviruses share essential replication gene functions with pathogenic ancestors
Wang et al. Specificity of baculovirus P6. 9 basic DNA-binding proteins and critical role of the C terminus in virion formation
Watanabe et al. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology
Kerr et al. The 5′ untranslated region of a novel infectious molecular clone of the dicistrovirus cricket paralysis virus modulates infection
KR20200038236A (en) Composition comprising curon and use thereof
Burke Common themes in three independently derived endogenous nudivirus elements in parasitoid wasps
Xiang et al. The Bombyx mori nucleopolyhedrovirus (BmNPV) ODV-E56 envelope protein is also a per os infectivity factor
CN110592172B (en) Method and target for screening JEV resistance gene by using CRISPR/Cas9 knockout library technology
CN112063634A (en) Attenuated African swine fever virus strain with gene deletion and application thereof
Tao et al. The Autographa californica multiple nucleopolyhedrovirus ORF78 is essential for budded virus production and general occlusion body formation
Leobold et al. The domestication of a large DNA virus by the wasp Venturia canescens involves targeted genome reduction through pseudogenization
CN112063633A (en) Attenuated African swine fever virus strain with deletion of natural immune suppressor gene and application thereof
Shrestha et al. Transcriptional responses of the Trichoplusia ni midgut to oral infection by the baculovirus Autographa californica multiple nucleopolyhedrovirus
Kueh et al. Virus‐like particle of Macrobrachium rosenbergii nodavirus produced in Spodoptera frugiperda (Sf9) cells is distinctive from that produced in Escherichia coli
Summer et al. Genomic and biological analysis of phage Xfas53 and related prophages of Xylella fastidiosa
Ding et al. Sequential deletions of interferon inhibitors MGF110-9L and MGF505-7R result in sterile immunity against the Eurasia strain of Africa swine fever
Muniraju et al. Kaposi sarcoma-associated herpesvirus glycoprotein H is indispensable for infection of epithelial, endothelial, and fibroblast cell types
Lee et al. Persistent baculovirus infection results from deletion of the apoptotic suppressor gene p35
Drezen et al. Evolutionary progenitors of bracoviruses
Serrano et al. Identification of Spodoptera exigua nucleopolyhedrovirus genes involved in pathogenicity and virulence
US9422575B2 (en) Polydnavirus delivery constructs

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees